How to Buy Dianthus Therapeutics Stock
Dianthus Therapeutics Inc
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases.
Dianthus Therapeutics stock last closed at $19.49, down 4.65% from the previous day, and has decreased 30.24% in one year. It has overperformed other stocks in the Biotechnology industry by 0.51 percentage points. Dianthus Therapeutics stock is currently +7.5% from its 52-week low of $18.13, and -40.83% from its 52-week high of $32.94.
At the moment, there are 32.13M DNTH shares outstanding. The market cap of DNTH is $626.12M. In the past 24 hours, 239,200 DNTH shares were traded.
How to Buy Dianthus Therapeutics Stock
Wondering how to invest in Dianthus Therapeutics stock? Here's how.
- Figure out where to buy Dianthus Therapeutics stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Dianthus Therapeutics stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Select your method of payment and add your info.
- Research Dianthus Therapeutics stock: The Dianthus Therapeutics ticker symbol is DNTH. Is Dianthus Therapeutics stock a good investment? Should you buy shares of DNTH? How do DNTH's underlying business fundamentals look? Do top analysts think Dianthus Therapeutics is a good buy? Why has DNTH's stock price moved recently? (Hint: Our stock research website can help you figure out if DNTH is a good stock to buy).
- Make your DNTH buy order: Decide if you will purchase DNTH shares at the current market price or use a limit order to buy DNTH shares at a given price.
- Get updates on your investment in DNTH: Create a watchlist to track your position in Dianthus Therapeutics shares.
Step 1: Figure out where to buy Dianthus Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy DNTH shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal information so you can buy DNTH today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have finished signing up on stock market apps, you can securely and quickly fund your account:
Watch this video walkthrough for more details depositing funds into your brokerage account.
Step 4: Research Dianthus Therapeutics stock
After you have figured out the best place to buy Dianthus Therapeutics stock, it's crucial to analyze their stock prior to investing, so you truly comprehend the risk as well as the opportunity.
Overview of key DNTH info
Fundamentals of Dianthus Therapeutics
WallStreetZen was designed to help average investors perform more accurate fundamental analysis.
You can see all of the due diligence checks on DNTH's stock page.
What is the fair value of DNTH stock?
You can use many financial metrics, analyses, models, and charts to gauge DNTH's intrinsic value.
Using relative valuations methods:
- DNTH may be undervalued based on its P/B ratio of 1.78x, relative to Biotechnology industry P/B ratio of 4.69x
You can do additional valuation research on DNTH's stock here.
DNTH Financial Health
Signs that DNTH is financially healthy:
- DNTH has cash burn of 78285000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the DNTH balance sheet.
- DNTH has $275.24M in cash and short term investments. This is sufficient to cover its annual cash burn of $78.29M.
- Total DNTH debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the DNTH balance sheet.
- DNTH has a low debt to equity ratio of 0.06.
Signs that DNTH is not financially healthy:
- DNTH profit margin has gone up by 1.78 percentage points in the past year, but the company is still unprofitable.
Is DNTH stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 5 sell side analysts who give ratings on DNTH, the consensus analyst rating on Dianthus Therapeutics is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Dianthus Therapeutics stock forecast page.
DNTH Technicals
DNTH Performance Numbers
Last year, DNTH revenue was $6.24M. Over the last two year, DNTH's revenue has increased by -1.43% per year. This was slower than the Biotechnology industry average of 45.96%.
Dig into DNTH's earnings and revenue performance here.
Latest Insiders Trades at DNTH
Over the last 12 months, executives and large shareholders at DNTH have not bought or sold any shares.
Dig into more about who owns DNTH shares here.
Does DNTH provide a stable income stream?
No, Dianthus Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about DNTH?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your DNTH buy order
You have two primary options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular price limit, place a limit order.
Hit the Open button and eToro will place the order.
If you want additional help buying stocks on eToro, click the helpful video below:
Step 6: Get updates on your investment in DNTH
Now that you own some shares in DNTH, you'll want to stay up-to-date on your new stock purchase.
Make a watchlist to get notified of the latest news about your DNTH stock.
DNTH Feed
How to Buy Stock in Dianthus Therapeutics
To reiterate, here are the 6 steps for buying Dianthus Therapeutics stock:
- Figure out where to buy Dianthus Therapeutics stock
- Create your brokerage account
- Fund your brokerage account
- Research Dianthus Therapeutics stock
- Make your DNTH buy order
- Get updates on your investment in DNTH
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Dianthus Therapeutics, create a watchlist today.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.